Alaunos Therapeutics (TCRT) Non-Current Assets (2009 - 2026)
Alaunos Therapeutics' (TCRT) quarterly Non-Current Assets came in at $913000.0 in Q1 2026, down 13.3% YoY from $1.1 million in Q1 2025, and down 6.65% on a QoQ basis from $978000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Non-Current Assets (2009 - 2026) Analysis & Trends
Alaunos Therapeutics (TCRT) has 17 years of Non-Current Assets data on file, last reported at $913000.0 in Q1 2026.
- Quarterly Non-Current Assets fell 13.3% year-over-year to $913000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 272.93% YoY) and the FY2025 annual result came in at $978000.0, changed N/A from the prior year.
- Non-Current Assets declined to $913000.0 in Q1 2026, from $978000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $15.2 million in Q1 2022 to a low of $2000.0 in Q4 2023.
- A 4-year average of $6.3 million and a median of $6.6 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets decreased 3.44% — and 2023, when it slumped 99.98%.
- Tracing TCRT's Non-Current Assets over 4 years: stood at $11.1 million in 2022, then tumbled by 99.98% to $2000.0 in 2023, then soared by 48800.0% to $978000.0 in 2025, then retreated by 6.65% to $913000.0 in 2026.
- The last three Non-Current Assets figures came in at $913000.0 (Q1 2026), $978000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | 850,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 913,000.00 |
| Dec 31, 2025 | 978,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 997,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 6.57 Mn |
| Jun 30, 2023 | 9.15 Mn |
| Mar 31, 2023 | 10.45 Mn |
| Dec 31, 2022 | 11.14 Mn |
| Sep 30, 2022 | 11.84 Mn |
| Jun 30, 2022 | 12.57 Mn |
| Mar 31, 2022 | 15.22 Mn |
| Dec 31, 2021 | 16.03 Mn |
| Sep 30, 2021 | 17.21 Mn |
| Jun 30, 2021 | 17.36 Mn |
| Mar 31, 2021 | 15.76 Mn |
| Dec 31, 2020 | 15.76 Mn |
| Sep 30, 2020 | 10.82 Mn |
| Jun 30, 2020 | 8.50 Mn |